gene therapy

Open Access
Analysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers
SANT P. CHAWLA, SAMANTHA JEFFREY, SKYLER S. PANG, ROBIN L. JONES, STEFAAN W. VAN GOOL, TIMO HUBER, JENNIFER KOSMAL, NEAL S. CHAWLA, RHEANNA CARTER, CHARLES B. SIMONE, KAMBIZ NAEL, HOWARD BRUCKNER, ANNA GATTANI, PAUL Y. SONG, FREDERICK L. HALL and ERLINDA M. GORDON

Anticancer Research April 2026, 46 (4) 2025-2034; DOI: https://doi.org/10.21873/anticanres.18091
Open Access
Proceedings of the Think Tank for Osteosarcoma Medical Advisory Board
SANT P. CHAWLA, BRIAN VAN TINE, NOAH FEDERMAN, JOSEPH SCHWAB, ROBIN JONES, VIVEK SUBBIAH, NEAL S. CHAWLA, NIMA AFSHAR, WILLY HOOS, NANCY FELDMAN, H. TRENT SPENCER, WILLIAM SWANEY and ERLINDA M. GORDON

Anticancer Research July 2024, 44 (7) 2765-2768; DOI: https://doi.org/10.21873/anticanres.17139
Open Access
From Mendel to Gene Therapy
SAMANTHA L. JEFFREY, DON A. BRIGHAM, SANT P. CHAWLA, NOAH FEDERMAN, FREDERICK L. HALL and ERLINDA M. GORDON

Anticancer Research October 2023, 43 (10) 4257-4261; DOI: https://doi.org/10.21873/anticanres.16620
Open Access
Early-stage CCNG1+ HR+ HER2+ Invasive Breast Carcinoma in Older Women: Current Treatment and Future Perspectives for DeltaRex-G, a CCNG1 Inhibitor
SANT P. CHAWLA, OLGA OLEVSKY, GEETA IYENGAR, DON A. BRIGHAM, NADEZHDA OMELCHENKO, SONU THOMAS, KUSHAL SURYAMOHAN, LELAND FOSHAG, FREDERICK L. HALL and ERLINDA M. GORDON

Anticancer Research June 2023, 43 (6) 2383-2391; DOI: https://doi.org/10.21873/anticanres.16406
You have access
SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study
TAIHEI KAJIYAMA, SATOSHI SERADA, MINORU FUJIMOTO, TOMOHARU OHKAWARA, MASAHIRO KOMORI, MASAMITSU HYODO and TETSUJI NAKA

Anticancer Research July 2022, 42 (7) 3361-3372; DOI: https://doi.org/10.21873/anticanres.15823
You have access
REIC/Dkk-3 Gene Therapy Induces Immunogenic Cell Death in a Mouse Model of Malignant Mesothelioma
KENJI ARAKI, NAOYA YAMAMURO, NAHOKO TOMONOBU and HIROMI KUMON

Anticancer Research October 2021, 41 (10) 4837-4855; DOI: https://doi.org/10.21873/anticanres.15298
You have access
Inhibition of Cell-surface Molecular GPR87 With GPR87-suppressing Adenoviral Vector Disturb Tumor Proliferation in Lung Cancer Cells
YUSUKE KITA, TETSUHIKO GO, NARIYASU NAKASHIMA, DAGE LIU, YOSHIMASA TOKUNAGA, XIA ZHANG, TAKAYUKI NAKANO, KAZUHITO NII, SUNG SOO CHANG and HIROYASU YOKOMISE

Anticancer Research February 2020, 40 (2) 733-741; DOI: https://doi.org/10.21873/anticanres.14004
You have access
Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma
HYE RIM HAN, SOON A. PARK, STEPHEN AHN, SIN-SOO JEUN and CHUNG HEON RYU

Anticancer Research December 2019, 39 (12) 6635-6643; DOI: https://doi.org/10.21873/anticanres.13878
You have access
Targeted Therapies for Pancreatic Cancer and Hurdles Ahead
MINELA ASLAN, REZA SHAHBAZI, KEZBAN ULUBAYRAM and BULENT OZPOLAT

Anticancer Research December 2018, 38 (12) 6591-6606; DOI: https://doi.org/10.21873/anticanres.13026
You have access
A Tumor-targeting Adenovirus with High Gene-transduction Efficiency for Primary Pancreatic Cancer and Ascites Cells
MASAKI NAGASATO, YOSEI RIN, YUKI YAMAMOTO, MARINA HENMI, NOBUYOSHI HIRAOKA, FUMIKO CHIWAKI, KEISUKE MATSUSAKI, MASATOSHI TAGAWA, HIROKI SASAKI and KAZUNORI AOKI

Anticancer Research July 2017, 37 (7) 3599-3605;

Main menu

User menu

Search

gene therapy

Pages